For decades, patients with inborn genetic diseases have been told a devastating message: your gene is broken, and there is nothing we can do to fix it. This view of “genetic determinism” — that genes are destiny — is one of the most destructive ideas in modern medicine. Ray Peat has always emphasized the opposite: metabolism is primary, and genes are secondary. A “genetic defect” only manifests as disease when the metabolic environment allows it to. The study below, published in Cell, proves this point dramatically. Researchers screened for genetic diseases that could be treated with vitamin B2 (riboflavin) and vitamin B3 (niacinamide/nicotinamide) . They found that dozens of genetic diseases — considered incurable — may be treatable with these simple, inexpensive vitamins. The mechanism is purely bioenergetic: B2 is a precursor to FAD , and B3 is a precursor to NAD+ . By supporting mitochondrial electron flow, these vitamins bypass or compensate for the underlying genetic defect.
When the researchers treated the knockout mice with daily injections of nicotinamide riboside (a form of vitamin B3) starting at birth, the rescue was dramatic. Eight of nine treated animals survived beyond day 50 — more than a 40-fold improvement in lifespan. Every aspect of the disease was rescued: body weight, brain pathology, cell death. When treatment was delayed by just two days, there was no benefit — highlighting the importance of early intervention.
The implications are staggering. The screen nominated dozens of additional genetic diseases that may respond to B2 or B3 therapy, and the researchers have only tested two out of more than 50 known micronutrients. This means that many “incurable” genetic diseases are not fundamentally incurable — they are metabolic bottlenecks that can be bypassed by supplying the right cofactors in sufficient quantity.
The human-equivalent dose is not explicitly stated in the article, but based on the mouse studies and previous clinical reports, the effective dose for NAXD disease is likely high-dose nicotinamide riboside or niacinamide — possibly in the range of 500–2,000 mg per day for an adult, with dose adjustment for body weight. For other genetic diseases identified in the screen, the optimal dose may vary, but the principle is the same: high-dose B vitamins can compensate for genetic defects in metabolism.
This study is a direct validation of the bioenergetic view. B2 (as FAD) and B3 (as NAD+) are essential cofactors for the electron transport chain. By supporting mitochondrial electron flow, these vitamins increase cellular energy production, which in turn allows cells to tolerate or compensate for genetic defects that would otherwise be fatal. The researchers explicitly state that their framework “picks up where the original vitamin hunters left off” — using modern tools to ask which vitamins can treat which diseases. I have been asking this question for years, and the answer is increasingly clear: vitamins are not just for preventing deficiency diseases. They are powerful metabolic therapies for a wide range of conditions, including those considered “genetic” and “incurable.”
https://doi.org/10.1016/j.cell.2026.01.022
“…In our new paper in Cell, we flip the traditional approach to finding cures. Instead of starting with one disease and spending a decade searching for a treatment, we start with a treatment that’s already safe and accessible and ask: what are all the genetic diseases it can treat?
“…We started with vitamins B2 and B3 because they’re common components of cell culture media… This yielded a list of dozens of disease genes that could be rescued by high vitamin B2 or B3 levels.
“…From the vitamin B3 screen, the top hit was the NAXD gene. Mutations in it cause a very rare disease… NAXD’s job is to convert NADHX back to usable NADH, correcting the errors before they cause damage. If people lack NAXD function, they develop severe neurodevelopmental disease that is often fatal in early childhood.
“…In the knockout mice, we saw massive accumulation of every form of NADHX across all tissues… NAD was specifically depleted in the brain and skin, which is where the disease shows up in human patients.
“…When we got it right, with daily intraperitoneal injections of nicotinamide riboside (one form of vitamin B3) starting at birth, the rescue was dramatic. Knockout mice were indistinguishable from their littermates at day 50 and beyond. Eight of nine treated animals continued to survive , more than a 40-fold improvement in lifespan. Every aspect of disease we measured was rescued.
“…Our screens nominated dozens of additional diseases that may respond to B2 or B3 therapy, and we’ve only tested two out of more than 50 known micronutrients.
“…We see this as picking up where the original vitamin hunters left off , bringing modern tools to the question of which vitamins can treat which diseases, and the mechanisms behind them.
